North Macedonia-Skopje: Medical equipments, pharmaceuticals and personal care products
2019/S 133-328428
Contract notice
Supplies Legal Basis:
Directive 2014/24/EU
Section I: Contracting authority I.1)Name and addresses Ministry of Health of Republic of North Macedonia 50 divizija No 6 Skopje 1000 The former Yugoslav Republic of Macedonia E-mail: tanja.pehcevska@zdravstvo.gov.mk NUTS code: MK
Internet address(es):
Main address: www.moh.gov.mk I.2)Information about joint procurement I.3)Communication The procurement documents are available for unrestricted and full direct access, free of charge, at: http://www.bjn.gov.mk/ Additional information can be obtained from the abovementioned address Tenders or requests to participate must be submitted electronically via: http://www.bjn.gov.mk/ I.4)Type of the contracting authority Ministry or any other national or federal authority, including their regional or local subdivisions I.5)Main activity Health
Section II: Object II.1)Scope of the procurement II.1.1)Title:
Specific Hematology Therapy for PHI UC for Hematology Skopje for a Period of 1 Year
II.1.2)Main CPV code 33000000 II.1.3)Type of contract Supplies II.1.4)Short description:
Specific hematology therapy for PHI UC for hematology Skopje for a period of 1 year.
II.1.5)Estimated total value II.1.6)Information about lots This contract is divided into lots: yes Tenders may be submitted for all lots II.2)Description II.2.1)Title:
Specific hematology therapy for PHI UC for hematology Skopje for a period of one year
Lot No: 1 - Lot No: 81
II.2.2)Additional CPV code(s) 33000000 II.2.3)Place of performance NUTS code: MK II.2.4)Description of the procurement:
Specific hematology therapy for PHI UC for hematology Skopje for a period of one year
II.2.5)Award criteria Criteria below Price II.2.6)Estimated value II.2.7)Duration of the contract, framework agreement or dynamic purchasing system Duration in months: 12 This contract is subject to renewal: no II.2.10)Information about variants Variants will be accepted: no II.2.11)Information about options Options: no II.2.12)Information about electronic catalogues II.2.13)Information about European Union funds The procurement is related to a project and/or programme financed by European Union funds: no II.2.14)Additional information
Section III: Legal, economic, financial and technical information III.1)Conditions for participation III.1.1)Suitability to pursue the professional activity, including requirements relating to enrolment on professional or trade registers List and brief description of conditions:
Confirmation issued from authorized body for compliance of special criteria for performing legal business activity related to the public procurement subject. A decision issued by the Agency for drugs and medical aids of RM, approving whole sale trading with drugs.
III.1.2)Economic and financial standing III.1.3)Technical and professional ability List and brief description of selection criteria:
List of employees responsible for the procurement phase, enclosing M1/M2 formulary for:
— declare a statement for engaged 24 hours available person for monitoring of the cold chain functioning and signalization in case of variations in the temperature range,
— declare a statement for full time employee with university degree in medicine or pharmacy in charge for pharmacovigilance and detection of problems in the drugs quality or errors in the drug’s series, submitting his/her data: name, surname, profession and contact phone in order to be available at any time,
— graduated pharmacist licensed to work in the procurement phases (reception, keeping and issuing drugs),
— submit notice for the parts of the procurement contract which the economic operator intends to transfer to subcontractor.
Minimum level(s) of standards possibly required:
— declare a statement that the conditions for drugs safe keeping, accommodation, transport and managing are fulfilled pursuant to the Guidance for the conditions related to the space, equipment and human resources for awarding approval for whole sale trade with drugs (Off. Gazette of RM No 151/08),
— declare a statement that at the moment of reception of the drugs, the expiry date shall be at least 12 months valid out of the total drugs expiry date,
— if the drug does not have trade approval in RM, then approval for trading in EU members, Norway, Switzerland, USA, Canada and Japan,
— Pharmaceutical Quality Assurance Certificate issued by the manufacturer not older then 3 years or CPP certificate issued by the manufacturer not older then 3 years,
— decision for trading with medicines in Macedonia or temporary approval for parallel import or final approval for parallel import pursuant to the Law on drugs and medical aids in RM.
III.1.5)Information about reserved contracts III.2)Conditions related to the contract III.2.2)Contract performance conditions: III.2.3)Information about staff responsible for the performance of the contract
Section IV: Procedure IV.1)Description IV.1.1)Type of procedure Open procedure IV.1.3)Information about a framework agreement or a dynamic purchasing system IV.1.4)Information about reduction of the number of solutions or tenders during negotiation or dialogue IV.1.6)Information about electronic auction IV.1.8)Information about the Government Procurement Agreement (GPA) The procurement is covered by the Government Procurement Agreement: no IV.2)Administrative information IV.2.1)Previous publication concerning this procedure IV.2.2)Time limit for receipt of tenders or requests to participate Date: 08/08/2019 Local time: 13:00 IV.2.3)Estimated date of dispatch of invitations to tender or to participate to selected candidates IV.2.4)Languages in which tenders or requests to participate may be submitted: Macedonian IV.2.6)Minimum time frame during which the tenderer must maintain the tender IV.2.7)Conditions for opening of tenders Date: 08/08/2019 Local time: 13:00
Section VI: Complementary information VI.1)Information about recurrence This is a recurrent procurement: no VI.2)Information about electronic workflows VI.3)Additional information: VI.4)Procedures for review VI.4.1)Review body State Appeals Commission Skopje The former Yugoslav Republic of Macedonia VI.4.2)Body responsible for mediation procedures VI.4.3)Review procedure VI.4.4)Service from which information about the review procedure may be obtained Ministry of Health of Republic of North Macedonia Skopje The former Yugoslav Republic of Macedonia VI.5)Date of dispatch of this notice: 10/07/2019
Hyperlinks to Related Project Dossiers:
https://ted.europa.eu/udl?uri=TED:NOTICE:328428-2019:TEXT:EN:HTML&src=0
|